After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Dyne Therapeutics Inc is $1.32B. A total of 5.45 million shares were traded on the day, compared to an average of 2.92M shares.
In the most recent transaction, Cox John bought 100,000 shares of DYN for 9.11 per share on Jul 14 ’25. After the transaction, the CEO & President now owns 242,179 company shares. In a previous transaction on Jun 11 ’25, Scalzo Richard William bought 1,330 shares at 14.75 per share.
Among the insiders who bought shares, Beskrovnaya Oxana acquired of 2,132 shares on Jun 11 ’25 at a per-share price of $14.75. In another insider transaction, Cox John sold 4,060 shares at $13.35 per share on Jun 05 ’25. Company shares held by the CEO & President now total 142,179.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, DYN has a high of $47.45 and a low of $6.36.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. DYN’s latest balance sheet shows that the firm has $376.57M in Cash & Short Term Investments as of fiscal 2021. There were $32.64M in debt and $28.72M in liabilities at the time. Its Book Value Per Share was $5.89, while its Total Shareholder’s Equity was $368.20M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DYN is Buy with a score of 4.65.
